Authors:
Massi, P
Vaccani, A
Romorini, S
Parolaro, D
Citation: P. Massi et al., Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects, J NEUROIMM, 117(1-2), 2001, pp. 116-124
Authors:
Ponti, W
Rubino, T
Bardotti, M
Poli, G
Parolaro, D
Citation: W. Ponti et al., Cannabinoids inhibit nitric oxide production in bone marrow derived felinemacrophages, VET IMMUNOL, 82(3-4), 2001, pp. 203-214
Citation: D. Braida et al., Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system, EUR J PHARM, 413(2-3), 2001, pp. 227-234
Authors:
Rubino, T
Vigano, D
Zagato, E
Sala, M
Parolaro, D
Citation: T. Rubino et al., In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: Behavioral and cellular responses after acute and chronic treatments, SYNAPSE, 35(1), 2000, pp. 8-14
Authors:
Sacerdote, P
Massi, P
Panerai, AE
Parolaro, D
Citation: P. Sacerdote et al., In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors, J NEUROIMM, 109(2), 2000, pp. 155-163
Authors:
Rubino, T
Vigano, D
Massi, P
Spinello, M
Zagato, E
Giagnoni, G
Parolaro, D
Citation: T. Rubino et al., Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions, NEUROPHARM, 39(7), 2000, pp. 1331-1336
Authors:
Rubino, T
Massi, P
Vigano, D
Fuzio, D
Parolaro, D
Citation: T. Rubino et al., Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome, LIFE SCI, 66(22), 2000, pp. 2213-2219
Authors:
Rubino, T
Vigano, D
Costa, B
Colleoni, M
Parolaro, D
Citation: T. Rubino et al., Loss of cannabinoid-stimulated guanosine 5 '-O-(3-[S-35]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats, J NEUROCHEM, 75(6), 2000, pp. 2478-2484
Citation: T. Rubino et al., Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940, J NEUROCHEM, 75(5), 2000, pp. 2080-2086
Authors:
Massi, P
Fuzio, D
Vigano, D
Sacerdote, P
Parolaro, D
Citation: P. Massi et al., Relative involvement of cannabinoid CB1 and CB2 receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity, EUR J PHARM, 387(3), 2000, pp. 343-347
Authors:
Basilico, L
Parolaro, D
Colleoni, M
Costa, B
Giagnoni, G
Citation: L. Basilico et al., Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexus, EUR J PHARM, 376(3), 1999, pp. 265-271
Authors:
Massi, P
Sacerdote, P
Ponti, W
Fuzio, D
Manfredi, B
Vigano, D
Rubino, T
Bardotti, M
Parolaro, D
Citation: P. Massi et al., Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters, J NEUROIMM, 92(1-2), 1998, pp. 60-66